期刊文献+

他汀类药物的非降脂作用应用评价 被引量:7

Evaluation of Applicational Progress in the Effect of Non-descendens Blood Fat of Statins
下载PDF
导出
摘要 目的:介绍他汀类药物的非降脂作用的应用进展,以期为临床合理应用提供参考。方法:查阅国内外近期相关文献,对他汀类药物除降脂之外的作用机理及相关进展作一评价。结果及结论:他汀类药物还具有治疗心血管疾病、骨质疏松,抗炎、抗肿瘤、抗病毒、免疫抑制,预防老年性痴呆症、糖尿病肾病、缺血性中风,降低糖尿病风险,应用于心血管外科、作用于顽固性类风湿性关节炎、辅助治疗多发性硬化等多方面的作用,是一种应用前景广阔的药物。 OBJECTIVE: To introduced applicational progress in the effect of non - descendens blood fat of statins, in order to provide some information for rational use in the clinic. METHODS: By reviewing recent pertinent literatures at home and abroad, to evaluate the mechanism of action of other effects of statins except for that of deseendens blood fat and their progress. RESULTS & CONCLUSION: Statins can also treat cardiovascular disease, osteoporosis, anti- inflammation, anti -tumor, anti- virus, immune suppression, prevent senile dementia, diabetic nephropathy, isehemie stroke and decrease diabetic risk. statins have already been used in cardiovascular surgery, refractory rheumatoid arthritis and multiple sclerosis, they are the drugs with wide applieational prospect.
作者 黄萍 蒙华
出处 《中国医院用药评价与分析》 2006年第1期17-21,共5页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 他汀类药物 非降脂作用 statins the effect of non - deseendens blood fat
  • 相关文献

参考文献32

二级参考文献162

  • 1正宗译.NSAID和他汀类药联用可能有防结肠癌作用[J].中国医学论坛报,1999,25(29):7-7.
  • 2邓万俊.急性心肌梗死后早期应用他汀类药物及1年存活率[J].国外医学:药学分册,2001,28(4):245-245.
  • 3邓杨梅.他汀类药物能否用于治疗骨质疏松[J].国外医学:药学分册,2001,28(2):124-124.
  • 4[1]Hartmann T. Cholesterol, A beta and Alzheimer's disease[J]. Trends Neurosci, 2001, 24(11 Suppl):S45.
  • 5[2]Petanceska SS, DeRosa S, Olm V, et al. Statin therapy for Alzheimer's disease:will it work?[J]. J Mol Neurosci, 2002,19(1-2):155.
  • 6[3]Wolozin B. Cholesterol and Alzheimer's disease[J]. Biochem Soc Trans, 2002,30(4):525.
  • 7[4]Simons M, Schwarzler F, Lutjohann D, et al. Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial[J]. Ann Neurol, 2002,52(3):346.
  • 8[5]Fassbender K, Simons M, Bergmann C, et al. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo[J]. Proc Natl Acad Sci,2001, 98(10):5856.
  • 9[6]Buxbaum JD, Geoghagen NS, Friedhoff LT. Cholesterol depletion with physiological concentrations of a statin decreases the formation of the Alzheimer amyloid Abeta peptide[J]. J Alzheimers Dis, 2001, 3(2):221.
  • 10[7]Buxbaum JD, Cullen EI, Friedhoff LT. Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients[J]. Front Biosci, 2002, 7:a50.

共引文献129

同被引文献43

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部